Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;42(11):1365-1386.
doi: 10.1007/s40618-019-01061-2. Epub 2019 May 20.

Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)

Collaborators, Affiliations

Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)

M Caprio et al. J Endocrinol Invest. 2019 Nov.

Abstract

Background: Weight loss is a milestone in the prevention of chronic diseases associated with high morbility and mortality in industrialized countries. Very-low calorie ketogenic diets (VLCKDs) are increasingly used in clinical practice for weight loss and management of obesity-related comorbidities. Despite evidence on the clinical benefits of VLCKDs is rapidly emerging, some concern still exists about their potential risks and their use in the long-term, due to paucity of clinical studies. Notably, there is an important lack of guidelines on this topic, and the use and implementation of VLCKDs occurs vastly in the absence of clear evidence-based indications.

Purpose: We describe here the biochemistry, benefits and risks of VLCKDs, and provide recommendations on the correct use of this therapeutic approach for weight loss and management of metabolic diseases at different stages of life.

Keywords: Cardiovascular rehabilitation; Cardiovascular risk; Ketone bodies; Obesity; Type 2 diabetes; Weight loss.

PubMed Disclaimer

Comment in

References

    1. J Clin Endocrinol Metab. 2015 Nov;100(11):3975-4011 - PubMed
    1. Nutr Rev. 2007 Jun;65(6 Pt 2):S64-8 - PubMed
    1. Osteoporos Int. 2006;17(9):1398-403 - PubMed
    1. Curr Hypertens Rep. 2018 Feb 26;20(2):12 - PubMed
    1. Mediators Inflamm. 2015;2015:105828 - PubMed

Publication types

LinkOut - more resources